Researchers share results from ongoing municipal science and technology project

Shanghai has achieved major breakthroughs in future intelligent technology fields, researchers in charge of a major municipal science and technology project said on Saturday.

Study: Effective vaccine response among young

The domestic COVID-19 vaccine developed by Sinovac Biotech is safe and can elicit a strong antibody response in people aged 3 to 17 in early and mid-stage clinical trials, according to a study published recently in a medical journal.

Sinovac vaccine 'well tolerated, safe and induced humoral responses' in minors aged 3-17

The world's first trial results on minors aged 3-17 showed China's inactivated COVID-19 vaccine produced by Sinovac had good safety, tolerability, and immunogenicity in youths aged 3-17 years, the Global Times learnt from Sinovac on Tuesday.

Efficacy of Sinopharm vaccines tops 70%, study finds

Domestic drugmaker Sinopharm's two vaccines are both more than 70 percent effective against symptomatic cases of COVID-19, according to a study published on Wednesday on the world's first third-stage clinical trial of inactivated vaccines.

China's innovative lung cancer drug application accepted for review by US FDA

Chinese drugmaker Innovent Biologics, Inc. and the US-based pharmaceutical firm Eli Lilly and Company announced that FDA accepted for review an application for Sintilimab, an innovative lung cancer drug jointly developed by the two companies.

TCM soup can help cut COVID-19 death rate of patients in half, study shows

Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

Fosun helps world fight malaria

Fosun Pharma has supplied more than 200 million doses of anti-malaria drugs to the international society since 2005 to help with the world's malaria elimination efforts, the company said on Sunday, which marked World Malaria Day.

Vaccine production site opens in Tianjin

China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX

BEIJING - China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying.

China's daily output of COVID-19 vaccines reaches 5 million doses

BEIJING -- The daily output of Chinese COVID-19 vaccines has reached 5 million doses, a senior official said.